Phosphonylmethyl ethers of acyclic nucleoside analogues: inhibitors of HSV-1 induced ribonucleotide reductase
Jazyk angličtina Země Nizozemsko Médium print
Typ dokumentu časopisecké články
PubMed
2168691
DOI
10.1016/0166-3542(90)90070-n
PII: 0166-3542(90)90070-N
Knihovny.cz E-zdroje
- MeSH
- adenin aplikace a dávkování analogy a deriváty farmakologie MeSH
- antivirové látky farmakologie MeSH
- fosforylace MeSH
- kultivované buňky MeSH
- organofosfonáty * MeSH
- organofosforové sloučeniny aplikace a dávkování farmakologie MeSH
- ribonukleotidreduktasy antagonisté a inhibitory MeSH
- Simplexvirus účinky léků MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- 9-(S)-(3-hydroxy-2-(phosphonomethoxy)propyl)adenine MeSH Prohlížeč
- adefovir MeSH Prohlížeč
- adenin MeSH
- antivirové látky MeSH
- organofosfonáty * MeSH
- organofosforové sloučeniny MeSH
- ribonukleotidreduktasy MeSH
Diphosphates of N-(S)-(3-hydroxy-2-phosphonylmethoxypropyl) and N-(2-phosphonylmethoxyethyl) derivatives of purine and pyrimidine heterocyclic bases inhibit HSV-1 encoded ribonucleotide reductase. Of the compounds studied, the most efficient inhibitors of CDP reduction (at 5.1 mumols.l-1) by the HSV-1-encoded enzyme are HPMPApp (IC50 = 0.9 mumols.l-1) and PMEApp (IC50 = 8 mumol.l-1). PMEApp does not inhibit the enzyme isolated from the mutant HSV-1 KOS strain PMEAr which is resistant to PMEA at a concentration of 100 micrograms/ml. The enzyme isolated from the PMEA-resistant virus strain is also insensitive to inhibitory effects of hydroxyurea and HPMPApp. Thus, the inhibitory potency of HPMPApp and PMEApp toward HSV-1 encoded ribonucleotide reductase might be connected with the anti-HSV activity of HPMPA and PMEA.
Citace poskytuje Crossref.org